z-logo
open-access-imgOpen Access
IMMUNE PROTECTION OF SALVINIA MOLESTA D.S. MITCHELL IN FRESHWATER CRAB OZIOTELPHUSA SENEX SENEX BACTERIALLY CHALLENGED WITH AEROMONAS HYDROPHILA
Author(s) -
Nithya Tg,
J. Jayanthi,
Ragunathan Mg,
D Devakumar
Publication year - 2017
Publication title -
asian journal of pharmaceutical and clinical research
Language(s) - English
Resource type - Journals
eISSN - 2455-3891
pISSN - 0974-2441
DOI - 10.22159/ajpcr.2017.v10i12.21461
Subject(s) - aeromonas hydrophila , biology , hemolymph , weed , microbiology and biotechnology , immune system , aeromonas , botany , fishery , immunology , bacteria , fish <actinopterygii> , genetics
  Objective: This is aimed to study the immune protection parameters of freshwater weed Salvinia molesta in bacterially challenged freshwater crab Oziotelphusa senex senex.Methods: In this present study, ethanolic extract of freshwater weed S. molesta was tested for its ability to induce immunity in bacterial challenged freshwater crab O. senex senex. Male and female crabs were challenged with Aeromonas hydrophila in relevant concentrations. The treated groups were allowed to withstand for 96 hrs. After relevant incubation time, the hemolymph of the treated crabs was subjected for various hematological, biochemical, and immunological assays.Results: Total hemocyte count increased on infection at 96 hrs, whereas significantly reduced on treatment with S. molesta at 96 hrs. All the three cell types of differential hemocytes showed significant positive changes on treatment. Levels of prophenoloxidase decreased significantly on infection and showed a significant increase in treated groups at 96 hrs of treatment.Conclusion: The present study elucidated the medicinal and pharmaceutical role of S. molesta weed which is been subjected to eradication in the recent days. Thus, the plant source can be utilized as an immunomodulatory agent and a better alternative to treat aquatic diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here